BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26082469)

  • 21. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.
    Thomas EA; Coppola G; Desplats PA; Tang B; Soragni E; Burnett R; Gao F; Fitzgerald KM; Borok JF; Herman D; Geschwind DH; Gottesfeld JM
    Proc Natl Acad Sci U S A; 2008 Oct; 105(40):15564-9. PubMed ID: 18829438
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fingolimod (FTY720) enhances hippocampal synaptic plasticity and memory in Huntington's disease by preventing p75NTR up-regulation and astrocyte-mediated inflammation.
    Miguez A; García-Díaz Barriga G; Brito V; Straccia M; Giralt A; Ginés S; Canals JM; Alberch J
    Hum Mol Genet; 2015 Sep; 24(17):4958-70. PubMed ID: 26063761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Behavioural state differentially engages septohippocampal cholinergic and GABAergic neurons in R6/1 Huntington's disease mice.
    Ransome MI; Hannan AJ
    Neurobiol Learn Mem; 2012 Feb; 97(2):261-70. PubMed ID: 22261461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical role of astrocyte-mediated nuclear factor-κB-dependent inflammation in Huntington's disease.
    Hsiao HY; Chen YC; Chen HM; Tu PH; Chern Y
    Hum Mol Genet; 2013 May; 22(9):1826-42. PubMed ID: 23372043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.
    Pépin J; Francelle L; Carrillo-de Sauvage MA; de Longprez L; Gipchtein P; Cambon K; Valette J; Brouillet E; Flament J
    Neuroimage; 2016 Oct; 139():53-64. PubMed ID: 27318215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. M2 Cortex Circuitry and Sensory-Induced Behavioral Alterations in Huntington's Disease: Role of Superior Colliculus.
    Conde-Berriozabal S; García-Gilabert L; García-García E; Sitjà-Roqueta L; López-Gil X; Muñoz-Moreno E; Boutagouga Boudjadja M; Soria G; Rodríguez MJ; Alberch J; Masana M
    J Neurosci; 2023 May; 43(18):3379-3390. PubMed ID: 37001992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuronal apoptosis and reversible motor deficit in dominant-negative GSK-3 conditional transgenic mice.
    Gómez-Sintes R; Hernández F; Bortolozzi A; Artigas F; Avila J; Zaratin P; Gotteland JP; Lucas JJ
    EMBO J; 2007 Jun; 26(11):2743-54. PubMed ID: 17510631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer's and Huntington's Disease.
    D'Mello SR
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive glycome profiling of Huntington's disease transgenic mice.
    Gizaw ST; Koda T; Amano M; Kamimura K; Ohashi T; Hinou H; Nishimura S
    Biochim Biophys Acta; 2015 Sep; 1850(9):1704-18. PubMed ID: 25907331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures.
    Cepeda-Prado E; Popp S; Khan U; Stefanov D; Rodríguez J; Menalled LB; Dow-Edwards D; Small SA; Moreno H
    J Neurosci; 2012 May; 32(19):6456-67. PubMed ID: 22573668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.
    Hickey MA; Zhu C; Medvedeva V; Lerner RP; Patassini S; Franich NR; Maiti P; Frautschy SA; Zeitlin S; Levine MS; Chesselet MF
    Mol Neurodegener; 2012 Apr; 7():12. PubMed ID: 22475209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain pericyte activation occurs early in Huntington's disease.
    Padel T; Roth M; Gaceb A; Li JY; Björkqvist M; Paul G
    Exp Neurol; 2018 Jul; 305():139-150. PubMed ID: 29630897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuronal apoptosis and motor deficits in mice with genetic inhibition of GSK-3 are Fas-dependent.
    Gómez-Sintes R; Lucas JJ
    PLoS One; 2013; 8(8):e70952. PubMed ID: 23940673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spatiotemporal mapping of brain atrophy in mouse models of Huntington's disease using longitudinal in vivo magnetic resonance imaging.
    Aggarwal M; Duan W; Hou Z; Rakesh N; Peng Q; Ross CA; Miller MI; Mori S; Zhang J
    Neuroimage; 2012 May; 60(4):2086-95. PubMed ID: 22342677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dietary fibre confers therapeutic effects in a preclinical model of Huntington's disease.
    Gubert C; Kong G; Costello C; Adams CD; Masson BA; Qin W; Choo J; Narayana VK; Rogers G; Renoir T; Furness JB; Hannan AJ
    Brain Behav Immun; 2024 Feb; 116():404-418. PubMed ID: 38142919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain mitochondrial iron accumulates in Huntington's disease, mediates mitochondrial dysfunction, and can be removed pharmacologically.
    Agrawal S; Fox J; Thyagarajan B; Fox JH
    Free Radic Biol Med; 2018 May; 120():317-329. PubMed ID: 29625173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SIRT2 ablation has no effect on tubulin acetylation in brain, cholesterol biosynthesis or the progression of Huntington's disease phenotypes in vivo.
    Bobrowska A; Donmez G; Weiss A; Guarente L; Bates G
    PLoS One; 2012; 7(4):e34805. PubMed ID: 22511966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic deletion of the Histone Deacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease.
    Ragot A; Pietropaolo S; Vincent J; Delage P; Zhang H; Allinquant B; Leinekugel X; Fischer A; Cho YH
    Brain Behav; 2015 Sep; 5(9):e00361. PubMed ID: 26445700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-semaphorin 4D immunotherapy ameliorates neuropathology and some cognitive impairment in the YAC128 mouse model of Huntington disease.
    Southwell AL; Franciosi S; Villanueva EB; Xie Y; Winter LA; Veeraraghavan J; Jonason A; Felczak B; Zhang W; Kovalik V; Waltl S; Hall G; Pouladi MA; Smith ES; Bowers WJ; Zauderer M; Hayden MR
    Neurobiol Dis; 2015 Apr; 76():46-56. PubMed ID: 25662335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of the Sexually Dimorphic Neuro-Inflammatory Response in a Transgenic Mouse Model of Huntington's Disease.
    Renoir T; Pang TY; Shikano Y; Li S; Hannan AJ
    J Huntingtons Dis; 2015; 4(4):297-303. PubMed ID: 26599196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.